Published in Gastroenterol Clin Biol on January 01, 1994
EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary. Ann Oncol (2003) 5.78
Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J Exp Med (1998) 5.59
Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group. N Engl J Med (1994) 5.19
Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study. Gut (2000) 4.02
Dissociation of vesicular stomatitis virus and relation of the virion proteins to the viral transcriptase. J Virol (1972) 3.84
Properties of the product synthesized by vesicular stomatitis virus particles. J Mol Biol (1971) 3.55
Calcium and fibre supplementation in prevention of colorectal adenoma recurrence: a randomised intervention trial. European Cancer Prevention Organisation Study Group. Lancet (2000) 3.26
Efficacy of topical and systemic itraconazole as a broad-spectrum antifungal agent in mycotic corneal ulcer. A preliminary study. Indian J Ophthalmol (2001) 2.96
Kinetics of RNA synthesis by vesicular stomatitis virus particles. J Mol Biol (1971) 2.86
Automatic record hash coding and linkage for epidemiological follow-up data confidentiality. Methods Inf Med (1998) 2.80
Survival of colorectal cancer patients in Europe during the period 1978-1989. EUROCARE Working Group. Eur J Cancer (1998) 2.74
Genome homology of vesicular stomatitis virus and defective T particles and evidence for the sequential transcription of the virion ribonucleic acid. J Virol (1972) 2.70
Crystal structure of SIV matrix antigen and implications for virus assembly. Nature (1995) 2.59
Abdominal tuberculosis. Diagnosis by fine needle aspiration cytology. Acta Cytol (1993) 2.26
Cancer incidence and mortality in France over the period 1978-2000. Rev Epidemiol Sante Publique (2003) 2.25
Late messenger RNA production by viable simian virus 40 mutants with deletions in the leader region. J Mol Biol (1981) 2.18
Complete sequence of bluetongue virus L2 RNA that codes for the antigen recognized by neutralizing antibodies. J Virol (1985) 2.17
Patterns of outcome and prognostic factors in primary large-cell lymphoma of the testis in a survey by the International Extranodal Lymphoma Study Group. J Clin Oncol (2003) 2.16
The association of cutaneous malignant melanoma with the use of sunbeds and sunlamps. Am J Epidemiol (1990) 2.11
Lymph node harvest reporting in patients with carcinoma of the large bowel: a French population-based study. Cancer (1998) 1.96
Initiation and direction of RNA transcription by vesicular stomatitis virus virion transcriptase. J Virol (1973) 1.95
Detection of homologous RNA sequences among six rhabdovirus genomes. J Virol (1974) 1.91
Cancer incidence and mortality in France over the period 1980-2005. Rev Epidemiol Sante Publique (2008) 1.88
Isolation and properties of poliovirus minus strand ribonucleic acid. J Virol (1970) 1.88
Colorectal adenocarcinoma in patients under 45 years of age: comparison with older patients in a well-defined French population. Dis Colon Rectum (2001) 1.87
Synthesis of bluetongue virus (BTV) corelike particles by a recombinant baculovirus expressing the two major structural core proteins of BTV. J Virol (1990) 1.78
Cancer survival increases in Europe, but international differences remain wide. Eur J Cancer (2001) 1.76
Unspliced functional late 19S mRNAs containing intervening sequences are produced by a late leader mutant of simian virus 40. Proc Natl Acad Sci U S A (1981) 1.71
Comparison of a low dose polyethylene glycol electrolyte solution with lactulose for treatment of chronic constipation. Gut (1999) 1.67
Tobacco, alcohol, and colorectal tumors: a multistep process. Am J Epidemiol (1995) 1.65
Effects of oxygenation and flow on the viability and function of rat hepatocytes cocultured in a microchannel flat-plate bioreactor. Biotechnol Bioeng (2001) 1.64
Colonoscopic screening in first-degree relatives of patients with 'sporadic' colorectal cancer: a case-control study. The Association Nationale des Gastroentérologues des Hôpitaux and Registre Bourguignon des Cancers Digestifs (INSERM CRI 9505) Gastroenterology (1998) 1.62
The crystal structure of bluetongue virus VP7. Nature (1995) 1.61
Incidence and patterns of recurrence after resection for cure of colonic cancer in a well defined population. Br J Surg (2006) 1.59
Behaviour of Chrysomya megacephala (Fabr.) and Hemipyrellia ligurriens (Wied.) as parasites of living animals under experimental conditions. S Afr J Med Sci (1971) 1.59
Complete sequence of the NS1 gene (M6 RNA) of US bluetongue virus serotype 10. Nucleic Acids Res (1987) 1.59
How to ensure data security of an epidemiological follow-up: quality assessment of an anonymous record linkage procedure. Int J Med Inform (1998) 1.58
Trends in the management and survival of digestive tract cancers among patients aged over 80 years. Aliment Pharmacol Ther (2005) 1.58
Schizophyllum commune as an emerging fungal pathogen: a review and report of two cases. Mycoses (2012) 1.48
Benefit of operative mortality reduction on colorectal cancer survival. Br J Surg (2002) 1.48
Nucleoside triphosphate phosphotransferase. A new enzyme activity of oncogenic and non-oncogenic "budding" viruses. Biochim Biophys Acta (1971) 1.47
Assembly of double-shelled, viruslike particles of bluetongue virus by the simultaneous expression of four structural proteins. J Virol (1990) 1.46
European guidelines for quality assurance in colorectal cancer screening and diagnosis: overview and introduction to the full supplement publication. Endoscopy (2012) 1.44
Spectrum of echocardiographic findings in bacterial endocarditis. Circulation (1976) 1.44
Tagging sentinel lymph nodes: a study of 100 patients with breast cancer. Eur J Cancer (1999) 1.44
Molecular basis of bluetongue virus neutralization. J Virol (1983) 1.41
[Appendectomy, cholecystectomy, cholelithiasis and colorectal cancer. A retrospective case control study at the Côte-d'Or]. Gastroenterol Clin Biol (1991) 1.40
Release of bluetongue virus-like particles from insect cells is mediated by BTV nonstructural protein NS3/NS3A. Virology (1993) 1.39
[How to choose in practice a model to describe the geographic variation of cancer incidence? Example of gastrointestinal cancers from Côte-d'Or]. Rev Epidemiol Sante Publique (2002) 1.39
Transiently decreased sialylation of thyrotropin (TSH) in a patient with the euthyroid sick syndrome. Thyroid (1997) 1.39
Contralateral relapse after surgery for breast cancer: evaluation of follow-up paradigms. Int J Clin Pract (2013) 1.39
Incidence and management of malignant digestive endocrine tumours in a well defined French population. Gut (2004) 1.39
Profilin-1 is a negative regulator of mammary carcinoma aggressiveness. Br J Cancer (2007) 1.39
Colorectal adenoma characteristics as predictors of recurrence. Dis Colon Rectum (2004) 1.38
Energy intake, body mass index, physical activity, and the colorectal adenoma-carcinoma sequence. Nutr Cancer (2001) 1.38
[A diagnostic strategy for isolated pulmonary nodules less than 2 cm in diameter]. Rev Mal Respir (2002) 1.37
[Disposable versus reusable biopsy forceps. A prospective cost analysis in the gastrointestinal endoscopy unit of the Dijon University Hospital]. Gastroenterol Clin Biol (2001) 1.37
Complete nucleotide sequence of the group-reactive antigen VP7 gene of bluetongue virus. Nucleic Acids Res (1988) 1.37
Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome. Blood (1998) 1.36
Three-dimensional structure of single-shelled bluetongue virus. J Virol (1992) 1.35
Prospective study of prognostic factors in patients with unresected hepatic metastases from colorectal cancer. Fondation Française de Cancérologie Digestive. Br J Surg (1995) 1.34
Nucleotide sequence of a cDNA clone of RNA segment 10 of bluetongue virus (serotype 10). J Gen Virol (1986) 1.34
Variation over time of the effects of prognostic factors in a population-based study of colon cancer: comparison of statistical models. Am J Epidemiol (1999) 1.34
Colon cancer in France: evidence for improvement in management and survival. Gut (2002) 1.34
Cloning of the bluetongue virus L3 gene. J Virol (1984) 1.33
Survival of cancer patients in France: a population-based study from The Association of the French Cancer Registries (FRANCIM). Eur J Cancer (2006) 1.33
Transcription of the influenza ribonucleic acid genome by a virion polymerase. 3. Completeness of the transcription process. J Virol (1972) 1.33
Survival differences between European and US patients with colorectal cancer: role of stage at diagnosis and surgery. Gut (2005) 1.32
Signatures of the hydrogen bonding in the infrared bands of water. J Chem Phys (2005) 1.30
Expression and functional characterization of bluetongue virus VP2 protein: role in cell entry. J Virol (1999) 1.29
Assembly of five bluetongue virus proteins expressed by recombinant baculoviruses: inclusion of the largest protein VP1 in the core and virus-like proteins. Virology (1991) 1.29
Diet and squamous-cell cancer of the oesophagus: a French multicentre case-control study. Int J Cancer (1998) 1.29
Structure of bluetongue virus particles by cryoelectron microscopy. J Struct Biol (1993) 1.29
Adenoma--carcinoma sequence or "de novo" carcinogenesis? A study of adenomatous remnants in a population-based series of large bowel cancers. Cancer (1992) 1.28
Bluetongue virus tubules made in insect cells by recombinant baculoviruses: expression of the NS1 gene of bluetongue virus serotype 10. J Virol (1988) 1.27
European health systems and cancer care. Ann Oncol (2003) 1.27
Three-dimensional reconstruction of baculovirus expressed bluetongue virus core-like particles by cryo-electron microscopy. Virology (1992) 1.26
Recombinant glutathione S-transferase/CD36 fusion proteins define an oxidized low density lipoprotein-binding domain. J Biol Chem (1998) 1.26
Public awareness of risk factors and screening for colorectal cancer in Europe. Eur J Cancer Prev (2004) 1.25
Synthesis of bluetongue virus-encoded phosphoprotein and formation of inclusion bodies by recombinant baculovirus in insect cells: it binds the single-stranded RNA species. J Gen Virol (1990) 1.24
Role of human liver microsomal CYP3A4 and CYP2B6 in catalyzing N-dechloroethylation of cyclophosphamide and ifosfamide. Biochem Pharmacol (2000) 1.24
Bluetongue virus VP6 protein binds ATP and exhibits an RNA-dependent ATPase function and a helicase activity that catalyze the unwinding of double-stranded RNA substrates. J Virol (1997) 1.24
Prognostic factors after curative resection for gastric cancer. A population-based study. Eur J Cancer (2000) 1.22
A soxA gene, encoding a diheme cytochrome c, and a sox locus, essential for sulfur oxidation in a new sulfur lithotrophic bacterium. J Bacteriol (2000) 1.22
An atomic model of the outer layer of the bluetongue virus core derived from X-ray crystallography and electron cryomicroscopy. Structure (1997) 1.21
Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays). Am J Ophthalmol (2004) 1.20
Temporally distinct accumulation of transcripts encoding enzymes of the prechorismate pathway in elicitor-treated, cultured tomato cells. Proc Natl Acad Sci U S A (1995) 1.19
Expression and functional characterization of bluetongue virus VP5 protein: role in cellular permeabilization. J Virol (2001) 1.19
Production and characterization of the neutralization antigen VP2 of bluetongue virus serotype 10 using a baculovirus expression vector. Virology (1987) 1.18
The expressed VP4 protein of bluetongue virus binds GTP and is the candidate guanylyl transferase of the virus. Virology (1992) 1.18
Epidemiology and prognosis of synchronous colorectal cancers. Br J Surg (2008) 1.17
Percutaneous balloon mitral valvotomy with the Inoue single-balloon catheter: commissural morphology as a determinant of outcome. J Am Coll Cardiol (1993) 1.17
[Microscopic hematuria in adults. Prevalence and associated factors]. Presse Med (1991) 1.17
The complete sequence of bluetongue virus serotype 10 segment 3 and its predicted VP3 polypeptide compared with those of BTV serotype 17. Virus Res (1985) 1.16
Study of V(1)-vascular vasopressin receptor gene microsatellite polymorphisms in human essential hypertension. J Mol Cell Cardiol (2000) 1.16